The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Bacillus clausii Probiotic Strains: Antimicrobial and Immunomodulatory Activities
Abstract
The clinical benefits observed with probiotic use are mainly attributed to the antimicrobial substances produced by probiotic strains and to their immunomodulatory effects. Currently, the best-documented probiotic bacteria used in human therapy are lactic acid bacteria. In contrast, studies aiming to characterize the mechanisms responsible for the probiotic beneficial effects of Bacillus are rare. The current work seeks to contribute to such characterization by evaluating the antimicrobial and immunomodulatory activities of probiotic B. clausii strains. B. clausii strains release antimicrobial substances in the medium. Moreover, the release of these antimicrobial substances was observed during stationary growth phase and coincided with sporulation. These substances were active against Gram-positive bacteria, in particular against Staphylococcus aureus, Enterococcus faecium, and Clostridium difficile. The antimicrobial activity was resistant to subtilisin, proteinase K, and chymotrypsin treatment, whereas it was sensitive to pronase treatment. The evaluation of the immunomodulatory properties of probiotic B. clausii strains was performed in vitro on Swiss and C57 Bl/6j murine cells. The authors demonstrate that these strains, in their vegetative forms, are able to induce NOS II synthetase activity, IFN-gamma production, and CD4 T-cell proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Hudault, S., Liévin, V, Bernet-Camard, M. F., & Servin, A. L. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.2.513-518.1997 · Cited by 329
Cited by
The use of bacterial spore formers as probiotics: Table 1
Hong, H. A., Duc, L. H., & Cutting, S. M. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.001 · Cited by 975
Diversity and applications of Bacillus bacteriocins
Abriouel, H., Franz, C. M. A. P., Omar, N. B., & Gálvez, A. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00244.x · Cited by 629
The Role of Probiotics and Prebiotics in Inducing Gut Immunity
Vieira, A. T., Teixeira, M. M., & Martins, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00445 · Cited by 273
Potential Use of Bacillus coagulans in the Food Industry
Konuray, G., & Erginkaya, Z. (2018) · Foods · doi:10.3390/foods7060092 · Cited by 259
Nista, E. C., Candelli, M., Cremonini, F., Cazzato, I. A., Zocco, M. A., Franceschi, F., Cammarota, G., Gasbarrini, G., & Gasbarrini, A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02274.x · Cited by 212
Metadata
- Authors
- Urdaci, M. C., Bressollier, P., & Pinchuk, I.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2004-07
- Volume
- 38
- Issue
- Supplement 2
- Pages
- S86-S90
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2136589285
- Cited by
- 182
- References
- 2
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacillus clausii Probiotic Strains: Antimicrobial and Immunomodulatory Activities. https://app.cochat.ai/papers/10.1097/01.mcg.0000128925.06662.69
- The paper
- Urdaci, M. C., Bressollier, P., & Pinchuk, I. (2004). Bacillus clausii Probiotic Strains: Antimicrobial and Immunomodulatory Activities. Journal of Clinical Gastroenterology. https://doi.org/10.1097/01.mcg.0000128925.06662.69
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.